FOLFIRI Plus Bevacizuamb and QL1706 in Second-Line Treatment for mCRC

Clinical trial NCT07729605 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07729605
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC)

Start date: 2026-07-30
Primary completion: 2028-12-30
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.